An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftin (Naftifine Hydrochloride) Cream, 2% in Pediatric Subjects With Tinea Corporis
Phase of Trial: Phase IV
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Naftifine (Primary)
- Indications Tinea corporis
- Focus Pharmacokinetics
- Sponsors Merz Pharma
- 12 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Oct 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 11 Sep 2015 Planned End Date changed from 1 Aug 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.